Remove 2001 Remove Compounding Remove Pharmaceutical Companies
article thumbnail

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

11 In order to market such a product, companies must apply for a THR but it should be noted that this is only granted to eligible products; ie, those used for minor health conditions (such as a cold) and without the supervision of a medical practitioner 10 (whether for diagnostic purposes or for prescription or monitoring of treatment).

FDA 103
article thumbnail

Molecular Farming: Paving a Modern Track for Pharmaceutical Sectors (Molecular Pharming)

PharmaShots

After the outbreak of any epidemic or pandemic, all the responsibilities come on the shoulders of pharmaceutical companies. With unprecedented diseases lurking on the corner, pharmaceutical companies, are now obligated to widen their conventional horizons and look for substitute practices in their drug development strategies.